In a significant move, the European Union has finalized a draft deal aimed at enhancing the local production of essential medicines. This initiative is designed to address ongoing concerns about supply shortages.
The agreement focuses on reducing the E.U.'s dependence on imported pharmaceuticals, which has become increasingly critical in light of recent global supply chain disruptions.
By boosting domestic production, the E.U. hopes to ensure a more stable and reliable supply of necessary medicines for its member states.